When it comes to diagnostic tests, OraSure is certain it can deliver results. The oral specimen kits and other diagnostic tests developed by OraSure Technologies are designed to detect drug use and certain infectious diseases, namely HIV. The company's OraSure products use oral specimens rather than traditional blood or urine based methods to test for HIV. Its Intercept line uses oral samples to test for marijuana, cocaine, opiates, PCP, and amphetamines. OraSure has also developed a rapid HIV blood diagnostic testing method. The company sells its products in the US and internationally through direct agents and independent distributors, primarily to public health clinics, hospitals, and doctors' offices.
201 to 500 Employees
TypeCompany - Public (OSUR)
Revenue$100 to $500 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2000